Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ERAS · against 557 other Healthcare companies listed in US-listed
Ranked #424 of 558 · scores higher than 22% of peers
Bars: peers in each 10-point band of the profitability score114 peers with a profitability score of 10–19, including ERAS · Click a bar to see the companies
Mainly because of its return on assets and return on invested capital, which are weaker than most Healthcare peers.
| Metric | ERAS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 517 reported | -74.9% | -7.0% | 18% | 33% | |
| Operating marginHigher is better · 479 reported | Not reported | -2.4% | — | — | 33% |
| Return on assetsHigher is better · 582 reported | -66.0% | -7.8% | 8% | 33% | |
| Return on equityHigher is better · 531 reported | -78.2% | -19.7% | 18% | Context only | |
| Gross marginHigher is better · 601 reported | 0.0% | 43.9% | 6% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 578M USD | 99 | 73 | |
| 412 | 3.9B USD | 13 | 52 | |
| 424 | 337M USD | 12 | 33 | |
| 424 | 487M USD | 12 | 24 | |
| 424 | 3.4B USD | 12 | 35 | |
| 424 | 5.1B USD | 12 | 35 | |
| 424 | 10.5B USD | 12 | 56 | |
| 424 | 319M USD | 12 | 28 | |
| 424 | 1.3B USD | 12 | 27 | |
| 424 | 421M USD | 12 | 52 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score